Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
Portland, Victoria-based Southern Ocean Biotech operates in Pharmaceutical Manufacturing. It is privately held, and its site is sobiotech.com.au. It holds one address on record, all in Australia. Headcount on record is 4. Its work is tagged abalone Peptide, health Supplement and nutraceutical Industry. One Australian registration (ABN) is a candidate match. It is listed alongside seven similar brands, mostly in Education.
ABN16627040224
| SOUTHERN OCEAN BIOTECH PTY LTD | ABN 16627040224 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Southern Ocean Biotech: Pioneering Marine-Based Health Solutions
Southern Ocean Biotech, based in Portland, Victoria, Australia, is at the forefront of marine biotechnology, dedicated to advancing health and wellness through sustainable and scientifically backed nutraceuticals. Our mission is to harness the unique bioactive properties of marine resources to create health solutions that serve both people and the planet.
Our flagship product, Abagen™, is a revolutionary anti-inflammatory supplement derived from Australian abalone. Developed over 16 years in collaboration with CSIRO, Australia’s national science agency, Abagen™ provides proven anti-inflammatory benefits and superior bioavailability, making it an ideal solution for joint health. Sourced sustainably from abalone by-products, Abagen™ reflects our commitment to environmental responsibility at every stage of its creation.
Our approach is rooted in scientific excellence, with every product validated through in-depth research to ensure its efficacy and quality. Utilizing advanced extraction techniques, we are able to maximize abalone’s therapeutic potential while minimizing environmental impact. This journey is led by Dr. Simone Osbourne, whose dedication and expertise guide our research, supported by our collaborations with CSIRO and FRDC.
Abagen™’s therapeutic benefits are protected by patented technology (WO2017124149), underscoring our commitment to cutting-edge research and innovative health solutions. As we continue to explore the broader applications of marine-derived bioactives, we envision a future where Southern Ocean Biotech leads the industry with sustainable, science-driven products that support a better quality of life.
If you’re passionate about health innovation and sustainability, we invite you to follow us for updates and insights as we unlock the therapeutic potential of the ocean.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Victoria entity on the ABR: SOUTHERN OCEAN BIOTECH PTY LTD (ABN 16 627 040 224), medium confidence.
4 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: 226 Browning St, Portland, Victoria 3305.
None linked to this brand.
Four tags on the brand's own list, among them Abalone Peptide, Health Supplement and Nutraceutical Industry.
6 profiles list Southern Ocean Biotech as a peer — 75th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Molecular Horizons Research Institute UOW and Venus Shell Systems list it back.